Waverley Pharma Inc (WAVE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.059x

Based on the latest financial reports, Waverley Pharma Inc (WAVE) has a cash flow conversion efficiency ratio of 0.059x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-138.86K ≈ $-100.45K USD) by net assets (CA$-2.36 Million ≈ $-1.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See WAVE net asset quality score to measure how much of total assets are equity-financed.

Waverley Pharma Inc - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Waverley Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check WAVE cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Waverley Pharma Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Waverley Pharma Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Inventis Ltd AU:IVT	-0.074x
Else Nutrition Holdings Inc TO:BABY	-0.708x
Cobra Resources PLC LSE:COBR	-0.060x
Vivakor Inc NASDAQ:VIVK	-0.540x
CML Microsystems Plc LSE:CML	0.030x
Sacks Parente Golf, Inc. Common Stock NASDAQ:SPGC	-0.252x
Ariana Resources plc LSE:AAU	-0.024x
Bitcoin Fund Unit TO:QBTC	-0.019x

Annual Cash Flow Conversion Efficiency for Waverley Pharma Inc (2015–2024)

The table below shows the annual cash flow conversion efficiency of Waverley Pharma Inc from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Waverley Pharma Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-2.03 Million ≈ $-1.47 Million	CA$-410.19K ≈ $-296.73K	0.202x	-77.52%
2023-12-31	CA$-1.14 Million ≈ $-822.30K	CA$-1.02 Million ≈ $-738.66K	0.898x	+513.44%
2022-12-31	CA$1.09 Million ≈ $789.27K	CA$-237.06K ≈ $-171.49K	-0.217x	+51.33%
2021-12-31	CA$1.79 Million ≈ $1.29 Million	CA$-798.78K ≈ $-577.82K	-0.446x	-152.15%
2020-12-31	CA$2.04 Million ≈ $1.48 Million	CA$-361.70K ≈ $-261.65K	-0.177x	+64.34%
2019-12-31	CA$2.85 Million ≈ $2.06 Million	CA$-1.41 Million ≈ $-1.02 Million	-0.497x	-35.82%
2018-12-31	CA$3.97 Million ≈ $2.87 Million	CA$-1.45 Million ≈ $-1.05 Million	-0.366x	-1600.85%
2017-12-31	CA$5.06 Million ≈ $3.66 Million	CA$-108.69K ≈ $-78.62K	-0.021x	-100.23%
2016-12-31	CA$-11.62K ≈ $-8.41K	CA$-108.69K ≈ $-78.62K	9.350x	-9.27%
2015-12-31	CA$-10.55K ≈ $-7.63K	CA$-108.69K ≈ $-78.62K	10.306x	--

About Waverley Pharma Inc

V:WAVE Canada Biotechnology

Market Cap

$976.57K

CA$1.35 Million CAD

Market Cap Rank

#30912 Global

#1642 in Canada

Share Price

CA$0.03

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.03

All Time High

CA$0.60